(+/-)-2-Azabicyclo[2.2.1]hept-5-en-3-one, 98.00%, 500g

2-Hydroxy-5-octanoylbenzoic acid, 97%, 1g

4-Methoxy-7H-furo[3,2-g]chromen-7-one, 98.0%, 5g

D-(+)-Galactose Anhydrous>98.0%(HPLC)500g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 10 m, Ø-Innen 0,32 mm, Filmd. 5,00 µm, 1 Stück

6-Hydroxy-2-methylnicotinonitrile, 95.0%, 1g

(1-(Pyridin-4-ylmethyl)piperidin-4-yl)methanol, 95.0%, 1g

Methyl 1-(tert-Butoxycarbonyl)-3-piperidinecarboxylate>98.0%(GC)25g

1-[3,5-bis(trifluoromethyl)phenyl]-3-[(S)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methyl]thiourea, 97, 5g

tert-Butyl 3-amino-5-nitro-1H-indazole-1-carboxylate, 95.0%, 1g

3-Chloro-2-fluorobenzyl bromide, 97.0%, 10g

N-(2-Methoxy-5-methylphenyl)-4-methylbenzenesulfonamide, 95%, 5g

N,N'-bis(2-phenylethyl)urea, 10g